November 5, 2024 C-Path Scientific Directors Belmonte, Kosinski to Present at 20th IDS Congress Paul Belmonte, C-Path’s Scientific Director, T1D Consortium, and Luke Kosinski, Director, Quantitative Medicine, will present...
September 30, 2024 TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction...
Critical Path Institute Launches Type 1 Diabetes Consortium March 20, 2017 Critical Path Institute Launches Type 1 Diabetes Consortium Tucson, Ariz., March 20, 2017 –Critical Path Institut
CDISC, C-Path and TransCelerate Announce Availability of New and Updated Standards for COPD, Virology and Diabetes March 30, 2016 CDISC, C-Path and TransCelerate Announce Availability of New and Updated Standards for COPD, Virology
CDISC and TransCelerate Announce Availability of New Standards for Diabetes and Cardiovascular Disease CDISC and TransCelerate Announce Availability of New Standards for Diabetes and Cardiovascular Disease Austin, TX – 19 Novemb